Annual CR Report 2011 Map Overview

Total Page:16

File Type:pdf, Size:1020Kb

Annual CR Report 2011 Map Overview Annual CR Report 2011 Map overview Where we operate Our Academic Information (AI) division, Taylor & Francis Group, includes With brands such as IBC, Euroforum and IIR, Informa’s the publishing imprints Routledge, Psychology Press, CRC Press, Taylor & Events & Training (ET) division is the world’s largest Francis and Garland Science. Publishing books and journals to the academic publicly-owned events, conference and training community, the division has expanded rapidly in recent years. organiser. Some of our leading events include Arab Health, IPEX, Cityscape and the Monaco Yacht Show. 1,518 150 3,741 185 NUMBER OF NUMBER OF COUNTRIES NUMBER OF NUMBER OF COUNTRIES STAFF AI SELLS INTO STAFF ET SELLS INTO Informa’s Professional & Commercial Information (PCI) division serves the industry Our Central Group Functions include Finance, IT, intelligence needs of corporations and governments. Its product platforms Legal, HR and Shared Services and support all of include structured databases, subscription based services, real-time news, books Informa’s businesses globally. and journals. The division incorporates brands such as Lloyd’s List, Datamonitor, Citeline, Informa Telecoms & Media and Informa Research Services. 1,626 155 1,345 NUMBER OF NUMBER OF COUNTRIES NUMBER OF STAFF PCI SELLS INTO STAFF 4 CR Report 2011 Content index Chief Executive’s Our 05 Introduction 12 People Highlights of Our 06 the year 16 Environment CR Director’s Our 07 Strategic Review 20 Community Our Governance Our Performance 08 Structure 24 at a Glance Our Our Objectives 09 Content 25 at a Glance CR Report 2011 5 Chief Executive’s Introduction Peter Rigby explains why integrity is the cornerstone of how we do business 2011 was an exciting year for CR at Informa. Our CR programme has become embedded into our core business strategy and we took great strides forward. What we offer as a company is fundamental to a thriving knowledge society. Our diverse range of academic journals, books, events, exhibitions and training helps individuals, organisations and societies make better decisions, understand critical issues and share their knowledge. In 2011 alone we sold into 190 countries. More than 7,500 academic institutions subscribe to our journals. In other words, our strength is our content. We have an enormous responsibility for the integrity and quality of the knowledge we provide. Our CR programme seeks to engage with this responsibility and supports our businesses in their day-to-day efforts. Unlike ‘hard’ sustainability impacts – like waste and carbon emissions – there are few established metrics to track and manage performance in content impact, integrity and quality. However, we remain up for the challenge and will continue to update our stakeholders on our progress. In 2011, we continued to build community partnerships and facilitate ways for our employees to get involved. Informa Group UK became patrons of the national UK youth charity, The Prince’s Trust, Taylor & Francis partnered with the National Literacy Trust, while IIR Middle East supported the establishment of Breast Cancer Arabia, an important medical knowledge and community website for the UAE. These are just a few examples of what we do - other fantastic community efforts are described in more detail later in this report. 2011 also saw significant progress in our environmental agenda. We established a process to gain a fuller picture of our office emissions globally, and engaged with our print supply chain to reduce their impact. Finally, I’ve been delighted to see our CR agenda devolving to our businesses: our Group CR function acts as facilitator and catalyst, with individual businesses taking ownership and responsibility. Among our employees, there is a real appetite to do more and to do it better. I see this firsthand when I visit our offices across the world. This is exactly where we want to be. I hope you enjoy reading this report and please let us know if there is anything we can do better. Peter Rigby If you have any feedback on the report, please do get in touch. Email: [email protected] 6 CR Report 2011 Highlights of the year 15 Informa titles included in the ‘Top 40 Provided access to 1,600 journals Sustainability Books’, a recent ranking and reference works through mobile produced by Cambridge University’s phones via Taylor & Francis Online. Programme for Sustainability Leadership. ‘Brain print’ Reach Investigated and decided to switch to Implemented a Global Sustainable Paper biodegradable poly-wrap for our journals: Policy, an important step towards fulfilling 2012 will now see over 1,000,000 journals our commitment to using only certified or sent out in this more environmentally recycled paper in our publications. friendly wrapping. Waste Sustainablematerials raw Increased attendance to webinars and Became a Patron of the nationwide UK courses run by Informa Academy by youth charity, the Prince’s Trust, to work in 19% compared with last year. partnership to develop key skills, confidence and motivation of young people. Community Developingstaff our partnerships Developed best practice guidance for our Increased our resources committed to events business to identify and actively community investment, benefitting the manage its major environmental impacts in local communities in which we operate. areas such as waste minimisation & recycling, transportation and project management. Sustainability Community guidance for events investment CR Report 2011 7 CR Director’s Strategic Review Emma Blaney explains how the CR strategy at Informa has evolved and why understanding the ‘brain print’ is our future priority Our vision 2011 saw the launch of a new vision for Informa – to become We have formed lasting partnerships with community the best knowledge provider. This is a bold vision and a partners, ensuring that our skills and resources are put to vision that is completely aligned with our CR strategy. Let use where they are most needed. We continue to engage me explain why. our employees through our fundraising and awareness programmes. As a company, we have progressed well Our evolution against our objectives, but our stakeholders – not least The CR challenge for a company like ours is that we operate our employees – expect us to go further. So, what’s next? in different segments of the media spectrum. Our businesses face different risks and opportunities, exacerbated by Looking to the future: towards the ‘brain print’ our global reach. We have come a long way in ensuring a The key challenge for companies that are serious about unified approach to CR, while maintaining the freedom of their responsibilities towards society is to align their CR our businesses to pursue the CR objectives that are most priorities with core business strategy. The one thing material to them. all our businesses have in common is that we strive to deliver reliable, relevant and trusted information as I notice how the perception of CR has changed from a and when needed. We want to be the best knowledge limited set of issues, such as volunteering and energy usage, provider. Full stop. to a much wider ranging awareness around our business products and processes. In short, we have added breadth As the media CR agenda develops, it has become and depth to the way we think about and practise CR. This increasingly evident that the biggest risks and indeed opens up possibilities. opportunities relate to our core business: our content. Therefore, whilst not neglecting the issues that are important Our performance to all companies - people, environment, communities - we While the past few years were all about empowering our want to step up our efforts around content. businesses to take ownership of the CR agenda, define objectives and put in place monitoring mechanisms, 2011 The focus on content comes with an aspiration to was a year of delivery on those objectives. inspire, challenge and support our many audiences – be they delegates at our conferences, subscribers to our On the content side, we have further integrated editorial and journals, readers of our books, or professionals in need of quality codes into our processes, to maintain our position as a timely information – on the most pressing challenges of trusted information provider. We received considerable external our time. We refer to this impact as our ‘brain print’ and recognition for our content and continue to innovate in terms this is the reason for our intriguing front cover. of delivery channels, accessibility and data protection. Undoubtedly this will be very challenging, as we On the people side, we launched an ethics policy to continue to convert this aspiration into action and put in help guide employees working in an increasingly global place key performance indicators to track our progress. environment and continue to be recognised as an employer While the methods for calculating carbon emissions and of choice by external bodies. other ‘hard’ impacts are fairly established, that cannot be said for the ‘brain print’. This is unchartered territory, not We developed best practice waste management guidance just for us, but for the media sector as a whole. We have for our events business and rolled out a global sustainable set ourselves a proper 21st century challenge and we are paper sourcing policy. Increasingly, we expect our suppliers up for it. to follow our environmental standards and have formalised our processes to make sure this happens. Emma Blaney 8 CR Report 2011 Informa Group continues to be a collection of well-known but distinct businesses. Over the past couple of years, we have developed a CR strategy that, insofar as possible, devolves responsibility for CR to each of our business divisions. We currently have 18 CR leaders across the businesses who work closely with their CEO/MD to develop and manage our CR programme in a way that matches their key priorities. Our Group CR function plays a key role in facilitating the flow of information, providing strategic insights and developing KPIs to meet our overall CR objectives.
Recommended publications
  • Expect the Unexpected: Building Business Value in a Changing World
    Expect the Unexpected: Building business value in a changing world kpmg.com KPMG INTERNATIONAL PART 1 b | Expect the Unexpected: Building business value in a changing world In this report we offer a starting point for discussion. We present a system of ten sustainability megaforces that will impact each and every business over the next 20 years. We want to build awareness that these forces do not act alone in predictable ways. They are interconnected. They interact. Disclaimer: Throughout this document, "KPMG" ["we," "our," and "us"] refers to KPMG International, a Swiss entity that serves as a coordinating entity for a network of independent member firms operating under the KPMG name, KPMG's Climate Change and Sustainability practice, and/or to any one or more of such firms. KPMG International provides no client services. © 2012 KPMG International Cooperative (“KPMG International”), a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. All rights reserved. Expect the Unexpected: Building business value in a changing world | c Foreword usinesses today are operating in an ever more At KPMG’s network of firms we have always been at the interconnected and globalized world. Supply chains forefront of developments that shape business behavior. Bstretch across continents and are vulnerable to We are working with organizations to help them understand disruption. Consumer demands and government policies the forces at work that will influence markets and impact are changing rapidly and will impact your bottom line if your profitability in the medium to long term.
    [Show full text]
  • 2015 Informa Investor Day
    2015 Informa Investor Day 18 November 2015 INTRODUCTION STEPHEN A. CARTER GROUP CHIEF EXECUTIVE 2015 Informa Investor Day Presentation Schedule • Introduction • Academic Publishing – Content Depth and Operating Efficiency • Global Exhibitions – Maximising the Growth Opportunity • Greenbuild – Overview & Tour • Lunch • Operational & Financial Update • Summary and Q&A THE JOURNEY SO FAR Stephen Carter appointed 2014 Investor Day Group CEO & launch of Disposal of Consumer Info. strategic review Review of strategic options for European Conferences Gareth Wright confirmed as Group FD, external appointment of BI and K&N Dwell acquisition FIME acquisition CEO’s 2013 2016 2014-2017 Growth Hanley Wood Disposal of Acceleration Plan Exhibitions acquisition Scandinavian announced and placing Conferences New operating Virgo acquisition Orlando Megacon Disposal of Dutch structure announced acquisition Conferences INFORMA GROUP INVESTOR DAY NOVEMBER 2015 4 2014-2017 GROWTH ACCELERATION PLAN FRAMEWORK Growth Acceleration Plan GAP GAP GAP GAP GAP GAP Operating Management Portfolio Acquisition Investment Funding Structure Model Management Strategy • 4 Operating Divisions • EMT established • Consumer Info disposal • Hanley Wood Exhib. • £70-90m programme • Renegotiated RCF • Global Support • Divisional SMTs • InsuranceIQ disposal • Virgo • 30-40 projects • $250m PPP issue • Medical Journals transfer • GE succession • Chinese Pharma closure • Orlando Megacon • 21 projects underway • Group Treasurer • WPA and Learning transfer • 3 yr business plans • Closure
    [Show full text]
  • Novartis Swaps Two Avexis Executives for One Following
    No. 3969 August 23, 2019 and CSO that the Kaspars have not been involved in the Novartis subsidiary’s op- erations since early May. Asked whether more AveXis employees will exit the company due to the preclini- cal safety data manipulation revealed on 6 August or whether other actions will be taken by Novartis in relation to the matter, Althoff told Scrip: “We cannot comment on the specifics of who is involved, but we can confirm this issue was not widespread, ei- ther in our overall dataset nor in our com- pany or any function within our company and was limited to a few individuals.” Novartis CEO Vas Narasimhan said in a 7 August conference call about the Zol- gensma data controversy that the compa- ny was in the process of “exiting the small number of AveXis scientists involved” in the data manipulation, which occurred Novartis Swaps Two AveXis before Novartis bought the gene therapy firm. (Also see “Novartis CEO Explains De- lay In Telling US FDA About Zolgensma Executives For One Following Data Fraud: We Wanted To Understand It First” - Pink Sheet, 7 Aug, 2019.) Zolgensma Data Manipulation Novartis acquired AveXis for $8.7bn MANDY JACKSON [email protected] last year. (Also see “Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisi- ovartis AG said when it disclosed the Zolgensma BLA was manipulated. Page tion” - Scrip, 9 Apr, 2018.) Zolgensma was that preclinical safety data for Zol- Bouchard, whose most recent function was the lead asset in AveXis’s R&D pipeline and Ngensma were manipulated in the bi- global head of preclinical safety for Novar- won US Food and Drug Administration ologic license application for the gene ther- tis Institutes of Biomedical Research (NIBR), approval in May, becoming the world’s apy that the company would be “exiting” was named senior vice president and chief most expensive drug with a $2m list price.
    [Show full text]
  • Informa 2018 Full Year Results Statement
    Informa LEI: 5493006VM2LKUPSEDU20 Press Release 7 March 2019 Informa PLC Results for 12 Months to 31 December 2018 2018: Combination & Creation 2019: Performance & Growth KEY FINANCIAL AND OPERATING HIGHLIGHTS1 • Strong Revenue Growth: +3.7% underlying and +34.9% reported to £2,369.5m, including six months of UBM (2017: £1,756.8m) • Higher Adjusted Operating Profit: +2.3% underlying and +34.4% reported to £732.1m (2017: £544.9m) • Improved Statutory Operating Profit: £363.2m (2017: £344.7m) • Increased Adjusted Diluted Earnings per Share: +7.0% to 49.2p (2017: 46.0p); Statutory EPS of 19.7p (2017: 37.6p), with prior year including non-cash credit from US tax reforms • Attractive Free Cash Flow: £503.2m and £600m+ including a full year of UBM (2017: £400.9m) • Robust Balance Sheet, in line with plan: Net debt/EBITDA1 at 2.9x (2017: 2.5x) • Enhanced Dividend: up 7.1% to 21.90p (2017: 20.45p) London: Informa (LSE: INF.L), the International Exhibitions, Events, Information Services and Scholarly Research Group, today published its financial results for the 12 months to 31 December 2018, reporting a further period of operational progress and improving financial performance. Stephen A. Carter, Group Chief Executive, said: “In 2018, the Informa Group delivered a fifth consecutive year of improving growth, increasing adjusted profits, adjusted earnings per share, cashflow and dividends.” He added: “In 2019, our focus is on continuing Performance and Growth as we consolidate our market positions and further reduce complexity. This will enable
    [Show full text]
  • The EBRARY Platform
    One eContent platform. Many ways to use it. Subscribe, Purchase or Customize Share, Archive & Distribute Integrate THE EBRARY PLatFORM Our eContent Your eContent eBooks, reports, journals, Theses, dissertations, images, journals, sheet music, and more eBooks – anything in PDF Subscribe Purchase Customize Share Archive Distribute SULAIR Select Collections SUL EBRARY COLLECTIONS Select Collections TABLE OF CONTENTS Infotools All ebrary Collections CONTRIBUTORS Byron Hoyt Sheet Music (Browse) INTRODUCTION Immigration Commision Reports (Dillingham) Contents BUSINESS: A USER’S GUIDE Women and Child Wage Earners in the U.S. CSLI Linguistics and Philosophy BEST PRACTICE SUL Books in the Public Domain MANAGEMENT CHECKLISTS Medieval and Modern Thought Text Project ACTIONLISTS MANAGEMENT LIBRARY BUSINESS THINKERS AND MANA DICTIONARY WORLD BUSINESS ALMANAC Highlights Notes BUSINESS INFORMATION SOURC INDEX CREDITS InfoTools Integrates Define Explain Locate multiple online Translate Search Document... resources Search All Documents... Search Web Search Catalog with one Highlight Add to Bookshelf customizable Copy Text... Copy Bookmark interface. Print... Print Again Toggle Automenu Preferences... Help About ebrary Reader... EASY TO USE. Subscribe, Purchase AFFORDABLE. or Customize your ALW ay S AVAILABLE. eBook selection NO CHECK-OUTS. Un I Q U E S U B SC R I B E T O G R OWI ng E B O O K D ataba S E S W I T H SIMULtanEOUS, MULTI-USER ACCESS. RESEARCH TOOLS. ACADEMIC DATABASES Academic Complete includes all academic databases listed below. FREE MARCS. # of # of Subject Titles* Subject Titles* Business & Economics 6,300 Language, Literature 3,400 & Linguistics “ebrary’s content is Computers & IT 2,800 Law, International Relations 3,800 multidisciplinary and Education 2,300 & Public Policy Engineering & Technology 3,700 supports our expanding Life Sciences 2,000 (includes Biotechnolgy, History & Political Science 4,800 Agriculture, and (also includes a bonus selection faculty and curriculum.
    [Show full text]
  • Annual Copyright License for Corporations
    Responsive Rights - Annual Copyright License for Corporations Publisher list Specific terms may apply to some publishers or works. Please refer to the Annual Copyright License search page at http://www.copyright.com/ to verify publisher participation and title coverage, as well as any applicable terms. Participating publishers include: Advance Central Services Advanstar Communications Inc. 1105 Media, Inc. Advantage Business Media 5m Publishing Advertising Educational Foundation A. M. Best Company AEGIS Publications LLC AACC International Aerospace Medical Associates AACE-Assn. for the Advancement of Computing in Education AFCHRON (African American Chronicles) AACECORP, Inc. African Studies Association AAIDD Agate Publishing Aavia Publishing, LLC Agence-France Presse ABC-CLIO Agricultural History Society ABDO Publishing Group AHC Media LLC Abingdon Press Ahmed Owolabi Adesanya Academy of General Dentistry Aidan Meehan Academy of Management (NY) Airforce Historical Foundation Academy Of Political Science Akademiai Kiado Access Intelligence Alan Guttmacher Institute ACM (Association for Computing Machinery) Albany Law Review of Albany Law School Acta Ecologica Sinica Alcohol Research Documentation, Inc. Acta Oceanologica Sinica Algora Publishing ACTA Publications Allerton Press Inc. Acta Scientiae Circumstantiae Allied Academies Inc. ACU Press Allied Media LLC Adenine Press Allured Business Media Adis Data Information Bv Allworth Press / Skyhorse Publishing Inc Administrative Science Quarterly AlphaMed Press 9/8/2015 AltaMira Press American
    [Show full text]
  • Global Business Information Specialist Informa’S Book Business Has More Than 55,000 Academic Advisers 26 Directors’ Report 27 and Business Titles
    Business Profile Business WHO WE ARE Business Profile 02 Annual Report & Financial Statements 2009 Our Business 03 Informa at a Glance 04 Academic Information 06 Professional & Commercial Information 08 Events & Training 10 Informa plc is a leading international provider of specialist information and services for the academic and scientific, professional and commercial business communities. Informa has some 150 offices in over 40 countries and employs approximately 8,000 staff around the world. Informa is the largest publicly-owned organiser of conferences and courses in the world with inThe Year The Year in Review 12 an output of around 8,000 events annually. Informa Financial Highlights 13 publishes over 2,100 subscription-based information Chairman’s Statement 14 services including academic journals, real-time news Chief Executive’s Review 16 Financial Review 19 R and structured databases of commercial intelligence. Board of Directors 24 eview Global Business Information Specialist Informa’s book business has more than 55,000 academic Advisers 26 Directors’ Report 27 and business titles. Corporate Governance Statement 38 Directors’ Remuneration Report 45 Corporate Responsibility 55 Financial Statements Financial Financial Statements 58 Independent Auditors’ Report – Group 59 Consolidated Income Statement 60 Consolidated Statement of Comprehensive Income 61 Consolidated Statement of Changes in Equity 62 Consolidated Statement of Financial Position 64 ”It was an extremely demanding year, Consolidated Cash Flow Statement 65 but one which
    [Show full text]
  • Informa Corporate Structure
    Corporate Structure From www.informa.com/Who-We-Are/Corporate-structure/ 5 March 2011 History Edward Lloyd pins the first ever copy of his shipping list to the wall of his coffee shop 1734 in Lombard Street, City of London. Richard Taylor publishes the first edition of The Philosophical Magazine, one of the 1798 first scientific journals produced by an independent company Dr William Francis joined Richard Taylor to found Taylor & Francis and continue the 1852 close links between the academic community and the company Taylor & Francis became a private limited company with leading scientists as 1936 directors and shareholders 1964 Investment & Property Studies founded as a part-time business International Business Communications Ltd (IBC) created to be an umbrella company 1971 for Investment & Property Studies and Legal Studies & Services The Institute for International Research (IIR) is launched by Irvine Laidlaw later to 1973 become Baron Laidlaw of Rothiemay – IIR becomes a specialist business conference organiser 1976 Euroforum established in Holland by IBC 1985 International Business Communications (Holdings) plc established Datamonitor is founded in London and produces its first ever report on the UK frozen 1989 food industry 1991 Launch of The Monaco Yacht Show by IIR Lloyd's List Publishing (LLP) and IBC Group plc merge to form the Informa Group 1998 plc Taylor & Francis successfully launched on the London Stock Exchange and shortly 1998 afterwards acquired the Routledge Group of companies Datamonitor, now a world-leading provider
    [Show full text]
  • Independent Auditor's Report to the Members of Informa
    Financial Statements Independent Auditor’s report to the members of Informa PLC Independent Auditor’s report to the members of Informa PLC Report on the audit of the financial statements The financial reporting framework that has been applied in Opinion the preparation of the Group financial statements is applicable In our opinion: law and IFRSs as adopted by the European Union. The financial reporting framework that has been applied in the preparation • the financial statements of Informa PLC and its of the parent company financial statements is applicable law subsidiaries (the “Group”) give a true and fair view of and United Kingdom Accounting Standards, including FRS 102 the state of the Group’s and of the parent company’s “The Financial Reporting Standard applicable in the UK and affairs as at 31 December 2018 and of the Group’s profit Republic of Ireland” (United Kingdom Generally Accepted for the year then ended; Accounting Practice). • the Group financial statements have been properly prepared in accordance with International Financial Reporting Basis for opinion Standards (IFRSs) as adopted by the European Union; We conducted our audit in accordance with International • the parent company financial statements have been properly Standards on Auditing (UK) (ISAs (UK)) and applicable law. prepared in accordance with United Kingdom Generally Our responsibilities under those standards are further Accepted Accounting Practice, including FRS 102 “The described in the auditor’s responsibilities for the audit Financial Reporting Standard applicable in the UK and of the financial statements section of our report. Republic of Ireland”; and • the financial statements have been prepared in accordance We are independent of the Group and the parent company in with the requirements of the Companies Act 2006 and, accordance with the ethical requirements that are relevant to as regards the Group financial statements, Article 4 of our audit of the financial statements in the UK, including the the IAS Regulation.
    [Show full text]
  • The Routledge Handbook of Neuroethics 1St Edition Pdf, Epub, Ebook
    THE ROUTLEDGE HANDBOOK OF NEUROETHICS 1ST EDITION PDF, EPUB, EBOOK Syd Johnson | 9781138898295 | | | | | The Routledge Handbook of Neuroethics 1st edition PDF Book Toggle navigation Menu. Terms and Conditions. Inbunden Engelska, The volume spotlights new technologies and historical articulations of key problems, issues, and concepts and includes cross-referencing between chapters to highlight the complex interactions of concepts and ideas within neuroethics. Routledge has grown considerably as a result of organic growth and acquisitions of other publishing companies and other publishers' titles by its parent company. After decades of almost exclusive sociological focus, criminology has undergone a paradigm shift where the field is more interdisciplinary and this book combines perspectives from criminology and sociology with contributions from fields such as genetics, neuropsychology, and evolutionary psychology. The past two decades have seen unparalleled developments in our knowledge of the brain and mind. Abstract: Adding to a small but growing feminist literature, this article critically examines popular, contemporary American sex manuals from a feminist social constructionist perspective, focusing specifically on how these manuals construct gender and sexual norms. In , in the case Adams v. Inside Book Publishing. Asexualities and Media. Don't waste your time, continue to see developments from around the world through BOOK. Given its scope, the book will appeal to scientists and students interested in the debate on animal ethics, while also offering an important resource for future researchers. The Independent. Categories : Academic publishing companies Book publishing companies of the United Kingdom Companies based in Oxfordshire Reference publishers Vale of White Horse mergers and acquisitions establishments in England Publishing companies established in Journal of Sex and Marital Therapy.
    [Show full text]
  • Informa Community Report:Layout 1
    Informa and the Community Be involved ... Be Involved ...in Informa’s Community programme Earlier this year, we asked you to tell us what you thought about Informa’s current community strategy. An impressive 627 of you responded to our survey, representing divisions and companies as diverse as Datamonitor, IBI, ICBI, IIR, iMoneynet, Omega, Psychology Press, T&F and many more. So, what did you tell us? • 99% of those that replied to the survey knew about our annual, and global, Go Bananas event to raise money for WCRF • 86% of respondents would be interested in getting involved with a local charity to their own office • 58% would rather give time to community activities than to both Involvedvolunteering and fundraising I We asked you how you would like to support Informa’s community activities.Be This is what you told us... Give time (volunteering) 24% Neither Fundraise 6% 12% ... A bit of both 58% 2 [email protected] So, what should Informa’s community strategy look like? Developing Local Partnerships We’d like to support Informa businesses across the world in building partnerships with local charitable projects. In order to help make this happen, we are therefore going to devolve control over community funding to each local business unit. This means that local businesses units will now be responsible for dealing with requests for matched funding from staff. We have also consulted with local MDs who have agreed to give every Informa employee a day off to take part in a volunteering activity. Informa’s Matched Funding Guidelines • We’d like
    [Show full text]
  • Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D
    Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D Stephanie Yip Senior Analyst, Datamonitor Healthcare 2 / May 2019 © Informa UK Ltd 2019 (Unauthorized photocopying prohibited.) The top 10 most lucrative drugs in 2018 were worth approximately $87bn The top 10 commercially successful drugs each generated at least $6.5bn in 2018 The top 10 drugs with the highest global sales in continued to dominate the pharmaceutical market; 2018 each generated revenues of at least $6.5bn its global sales of $20.4bn were equivalent to (see Table 1). The total sales value of these drugs approximately 23% of the top 10 drugs’ total sales. amounted to an astounding $87bn in 2018. To put Easily head and shoulders above the rest, Humira’s this into context, this is comparable to the $90bn substantial lead margin of $10.7bn was worth more in pharmaceutical R&D expenditure across the US than the worldwide sales ($9.7bn) of the second and EU in 2016.1 Humira (adalimumab; AbbVie/Eisai) leading drug, Revlimid (lenalidomide; Celgene).2-5 Table 1. Highest-selling drugs in 2018 Rank Global sales, 2018 Brand (molecule) Companies (total sales by company) 1 $20.4bn Humira (adalimumab) AbbVie ($19,936m), Eisai (¥46,300m*) 2 $9.7bn Revlimid (lenalidomide) Celgene ($9,685m) 3 $7.6bn Opdivo (nivolumab) Bristol-Myers Squibb ($6,735m), Ono Pharmaceutical (¥92,400m*) 4 $7.5bn Enbrel (etanercept) Amgen ($5,014m), Pfi zer ($2,112m), Takeda (¥35,900*) 5 $7.2bn Herceptin (trastuzumab) Roche (CHF6,982m) 5 $7.2bn Keytruda (pembrolizumab) Merck & Co ($7,171m) 7 $7.1bn Avastin (bevacizumab) Roche (CHF6,849m) 8 $7.0bn Rituxan (rituximab) Roche (CHF6,752m) 9 $6.7bn Eylea (afl ibercept) Regeneron ($6,746m) 10 $6.6bn Xarelto (rivaroxaban) Bayer (€3,631m), Johnson & Johnson ($2,477m) *Sum of Q1–Q3 2018 sales and Q4 2017 sales.
    [Show full text]